Stock Rich List
#532 on the corporate holders of 813 holders

Mpm Asset Management LLC

10% owner at Aktis Oncology; Insider at Werewolf Therapeutics.

$153M
in disclosed stock, +$2.4M (+1.58%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
532nd of 813
Companies held
2
Largest holding
AKTS, 95.7% of total
Latest SEC filing
Jan 12, 2026
Listed but not counted
$31.9M

What the $153M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Aktis Oncology AKTS
Common Stock
Indirectly (see filing footnote)
Reported jointly by 2 insiders; split evenly
5,130,032$16.40$84.1M55.0%Form 4, Jan 12, 2026
Aktis Oncology AKTS
Common Stock
Indirectly (see filing footnote)
Reported jointly by 2 insiders; split evenly
3,785,084$16.40$62.1M40.6%Form 4, Jan 12, 2026
Werewolf Therapeutics HOWL
Common Stock
Through AM LLC6,718,670$0.99$6.6M4.3%Form 4, Mar 27, 2025

Share counts are the amounts Mpm Asset Management LLC reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Mpm Asset Management LLC's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Aktis Oncology AKTS
Common Stock
Through MPM Asset Management LLC
Held by an investment fund or partnership
1,655,971$16.40$27.2M—Form 4, Jan 12, 2026
Werewolf Therapeutics HOWL
Common Stock
Through AM LLC
Held by a company or fund the insider manages
4,784,111$0.99$4.7M—Form 4, Dec 4, 2025

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Jan 12, 2026BoughtAKTS1,112,777$18.00$20.0MView
Dec 4, 2025SoldHOWL83,230$0.97$81KView
Dec 3, 2025SoldHOWL57,225$0.87$50KView
Dec 2, 2025SoldHOWL59,277$0.89$53KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
529Yorktown Energy Partners IX, L.P.
10% owner, Riley Exploration Permian
$154M−$637K (−0.41%)
530Third Rock Ventures V, L.P.
Director, Rapport Therapeutics
$154M+$1.2M (+0.81%)
531New Enterprise Associates 14, L.P.
10% owner, Enliven Therapeutics
$153M+$5.0M (+3.39%)
532Mpm Asset Management LLC
10% owner, Aktis Oncology
$153M+$2.4M (+1.58%)
533RC IV Cayman ICW Equity LLC
Insider, Driven Brands Holdings
$152M−$2.1M (−1.37%)
534Honeywell International INC
10% owner, Quantinuum
$152M−$567K (−0.37%)
535Casdin Partners FO1-MSV, LP
10% owner, GeneDx Holdings
$152M−$8.1M (−5.06%)

Other Aktis Oncology insiders

All AKTS insiders

Questions

How much stock does Mpm Asset Management LLC own?

Mpm Asset Management LLC holds $152,832,511 in listed stock based on SEC filings and current prices, mostly Aktis Oncology (AKTS). That ranks 532nd on the Stock Rich List.

Is this Mpm Asset Management LLC's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Mpm Asset Management LLC last buy or sell stock?

The most recent open-market trade on file is a purchase of 1,112,777 AKTS shares on Jan 12, 2026 at $18.00.

Files jointly with Ansbert Gadicke.